Work participation and work disability in Belgian patients with systemic sclerosis
- 22 December 2025
- journal article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 65 (1)
Abstract
Objectives: (1) Update data on work participation among patients with SSc followed in a multidisciplinary setting at a Belgian reference centre; (2) Investigate associations between work outcomes, personal, disease-related and contextual factors. Methods: One hundred and eight adult SSc patients, 84% fulfilling the 2013 ACR/EULAR criteria for SSc, were questioned on their socio-economic status during outpatient visits at Ghent University Hospital (February 2020–March 2021). Employment rate was compared with the general population after adjustment for age and sex. Associations between two work-related outcomes and socio-demographic and clinical variables were explored through binary logistic regression (outcome 1: having a paid job) and negative binomial regression (outcome 2: sick leave). Results: Among 81/108 (75%) participants of working age (18–65 y/o), crude employment rate was 64%, corresponding to a standardized employment ratio of 0.90 (95% CI 0.69–1.17). Work disability was the most common reason for not having a paid job (20%), with patients being older, less well educated and more functionally impaired compared with those with a paid job. Health-related sick leave in the previous year was substantial (79%); the number of days absent from work was significantly associated with internal organ involvement (incidence rate ratio, IRR, 0.3 [95% CI 0.1–0.8]) and working full-time (IRR 0.3 [95% CI 0.1–0.7]). Conclusion: Work participation in SSc patients is comparable to the general population, although work disability and sick leave remain substantial. Socio-demographic and job-related factors should be taken into account when assessing work outcomes in SSc, rather than basing work outcomes on disease characteristics alone.Keywords
Funding Information
- Fund Benevermedex (2020-J5162090–217752)
- Research Foundation—Flanders (Belgium) (1.8.029.20N)
This publication has 25 references indexed in Scilit:
- Flemish network on rare connective tissue diseases (CTD): patient pathways in systemic sclerosis. First steps takenActa Clinica Belgica, 2023
- Systemic sclerosisThe Lancet, 2022
- Work Productivity and Economic Burden of Systemic Sclerosis in a Multiethnic Asian PopulationArthritis Care & Research, 2022
- Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS)The Lancet Rheumatology, 2021
- Incidence, prevalence and long-term progression of Goh algorithm rated interstitial lung disease in systemic sclerosis in two independent cohorts in flanders: A retrospective cohort studySeminars in Arthritis and Rheumatism, 2021
- A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SScBest Practice & Research Clinical Rheumatology, 2021
- Employment outcomes in systemic sclerosisBest Practice & Research Clinical Rheumatology, 2021
- Belgian population norms for the EQ-5D-5L, 2018Quality of Life Research, 2021
- The value of the health assessment questionnaire and special patient‐generated scales to demonstrate change in systemic sclerosis patients over timeArthritis & Rheumatism, 1997
- Measurement of patient outcome in arthritisArthritis & Rheumatism, 1980